A123
De-identified Human Immune Atlas donor/sample detail for Neutrophil_LiverCancer_Nature_2022. The record preserves available public metadata while avoiding direct identifiers.
Primary Metadata
Core de-identified metadata fields migrated from the ImmuneAging donor manifest.
Donor ID
A123
Sample ID
A123_HCC, A123_HCC_B, A123_HCC_N
Dataset
Neutrophil_LiverCancer_Nature_2022
Cohort
Human liver cancer cohort, 124 patients
Age / Age Group
58 years
Sex
Male
Health Status
Hepatocellular carcinoma (HCC); TNM I; BCLC A
Tissue / Cell Source
tumor tissue; peripheral blood; adjacent liver tissue
Modality
scRNA-seq
Cell Count
18,340
Analysis Status
Published scRNA-seq
UMAP Status
Ready
Metadata / Source Notes
Source: Nature Supplementary Table 1a/1b; patient samples: A123_HCC, A123_HCC_B, A123_HCC_N; library samples: A123_HCC, A123_HCC_B, A123_HCC_N; no. PB samples: 1; no. adjacent liver samples: 1; no. tumor samples: 1; differentiation: High; venous invasion: 0; cirrhosis: 0
Additional Clinical / Source Fields
Supplementary source metadata retained from the migrated manifest where available.
cancer type
Hepatocellular carcinoma
cancer type short
HCC
tnm stage
I
bclc stage
A
virus
NBNC
tumor size cm
1.2*1.1
differentiation
High
venous invasion
0
cirrhosis
0
afp ug l
2.85
ca199 u ml
22.35
cea ug l
2.57
library count
3
library sample ids
A123_HCC, A123_HCC_B, A123_HCC_N
total reads
1249504407
source reference
Xue et al., Nature 612, 141-147 (2022), Supplementary Table 1
data accession
PRJCA007744
article url